In Vitro Fertilization Market Share

Global In Vitro Fertilization Market Overview

In Vitro Fertilization Market Size was valued at USD 12.34 Billion in 2023. The Global In Vitro Fertilization industry is projected to grow from USD 13.57 Billion in 2024 to USD 29.39 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.14% during the forecast period (2024 - 2032). High average conception age and robust regulatory frameworks are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

MilliporeSigma announced the debut of its new CellToxTM Assay Platform in June 2023. The platform is a range of in vitro experiments that test materials and drugs for safety.

In May 2023, WuXi AppTec expanded its capabilities in toxicology testing using in vitro. New assays will be included in this expansion, as well as a new service for custom-made IVAs.

Thermo Fisher Scientific Inc. noted it had bought CooperSurgical, an IVF provider of goods and services, in April 2023. The acquisition would help Thermo Fisher grow its market share in the In-Vitro Fertilization (IVF) sector.

The CryoTop vitrification device has been approved by the FDA, according to Vitrolife’s statement in March 2023. The CryoTop system is a novel technique for vitrifying embryos—a fast freezing technique preserving their viability.

In May 2023, AIVF, which develops AI-based solutions for IVF clinics, and Genea Biomedx jointly launched an integrated system. This recent integration links Genea Biomedx’s Geri time-lapse incubator with AIVF’s innovative EMA AI platform to provide personalized and better care across different IVF clinics worldwide.

June 2022 marked the emergence of Oma Fertility from stealth mode, introducing the first-ever network fertility clinics enabling families access to science-forward and AI-informed fertility treatments and creating a new standard for the success rate of IVFs.

In June 2023, Progyny, Inc. and Quantum Health, Inc. consolidated efforts towards bringing Quantum Health's Comprehensive Care treatments platform designed for family formation and reproductive treatments to market.

January 2022 saw Boston IVF link up with Delaware Institute for Reproductive Medicine (DIRM), one of the most experienced infertility centers globally. Local world-class treatment options such as preimplantation genetic testing (IVF), IVF, male infertility, and others are expected as a result of the partnership.

In May 2023, Pacific Blue Cross introduced an enhanced Personal Health Insurance, a health & dental plan that includes fertility drugs, fertility treatments, and adoption under family planning benefits. Pacific Blue Cross is the first and only provider in Canada to offer family planning benefits as part of an individual health & dental plan upon this improvement. This led to competitive pricing and moderated IVF treatment costs. This procedure has been successfully practiced as a technology, driving the market with more treatment automation and standardization.

In Vitro Fertilization Market Trends

• Growing Prevalence of robust regulatory framework to boost market growth

These have been a major concern that are attempted to be addressed by the medical fraternity. The root cause of the same can be traced back to delayed pregnancies lead to the risk of infertility and pregnancy related problems. The growth of assisted reproductive technologies, such as embryo culture media market, has been made possible by the availability of appropriate regulatory frameworks. However, in poorer nations, their penetration is still comparatively sluggish.

Further, the worldwide in vitro fertilization industry has seen a dramatic increase in the average age of first time mothers. This tendency is attributed, according to estimates, to better contraceptive methods and the rising number of women who choose to put off having children.

As per the data published by Australian Institute of Health and welfare 2021, the average age of first-time mothers increased from 27.9 years in 2009 to 31.9 years in 2019. The average age for first-time mothers growing, an increasing number of women are expected to face problems in conceiving naturally. In this scenario, a growing number of women are forced to opt for IVF treatments, such medical treatments for conceiving or to be first-time mothers has enhanced the market CAGR across the globe in the recent year.

In Vitro Fertilization Market Segment Insights

In Vitro Fertilization Type Insights

The market segments of in vitro fertilization, based on type, includes intrauterine insemination, intracytoplasmic sperm injection, and Ivf using donor eggs. The intrauterine insemination in vitro fertilization segment held the majority share in 2022 contribution in respect to the in vitro fertilization market revenue. This is primarily owing to the rising prevalence of delayed marriages and opt for artificial fertilization across the globe. For instance, as per the World Health Organization (WHO), globally 8%-10% of couples suffer from infertility which is approximate 80 billion couples worldwide.

In Vitro Fertilization Devices Insights

The in vitro fertilization market segmentation, based on devices, includes imaging systems, sperm separation system, ovum aspiration pump, micromanipulator, and cryosystem. All the devices uniformly perform in the market and is projected to be the faster-growing segment during the forecast period, 2024-2030. This is due to the increasing preference for IVF devices to become parents. Hence, rising use of these devices for In Vitro Fertilization positively impacts the market growth.

In Vitro Fertilization Reagents Insights

The in vitro fertilization market data has been bifurcated by reagents into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. The embryo culture media segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. Increasing population and decreasing fertility rate, increasing awareness about in vitro fertilization, and high disposable income are the factors due to which the embryo culture media segment grow in the near future.

2021: Hamilton Thorne Ltd. received FDA approval for the GYNEMED GM501, in US and Europe a ready-to-use medium has designed for in vitro washing and handling procedures of human oocytes and embryos. This approval has further broadened the growth opportunity for the in vitro fertilization industry.

Figure 1: In Vitro Fertilization Market, by Surgery, 2022 & 2032 (USD billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

In Vitro Fertilization End User Insights

Based on End Users, the in vitro fertilization industry has been segmented into clinical research institutes, fertility clinics, and hospitals. Fertility clinics held the largest segment share in 2022, owing to the rapid adoption of advanced in vitro fertilization products. Moreover, increasing government initiatives to aware about in vitro fertilization and high disposable income is expected to bolster the market of in vitro fertilization during the assessed timeline.

The fastest growing segment in the in vitro fertilization industry is hospitals. Increased availability and accessibility of possible treatments can be recognized to an increased preference for hospitals for infertility treatments.

In Vitro Fertilization Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America in vitro fertilization market accounted for USD 10.76 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to a lesser birthrate, which linked to various socioeconomic influences across the region.

Figure 2: In vitro fertilization market share by region 2022 (%)